ArticleVox sanguinis2025
Securing commitment and control for the supply of plasma derivatives for public health systems. II: A survey of national pathways.
Article in Vox sanguinis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Protection of fundamental human rights by improving patient access to plasma-derived therapies and donor health protection.Vox sanguinis · 2026Review
- Securing commitment and control for the supply of plasma derivatives for public health systems. II: A survey of national pathways.Vox sanguinis · 2025Article
- [Strategic independence: a value model for improving access to plasma-derived medicines in Latin AmericaIndependência estratégica: modelo de valor para melhorar o acesso a hemoderivados na América Latina].Revista panamericana de salud publica = Pan American journal of public health · 2025Article
- Prehospital whole blood after SWiFT and TOWAR: not superior, not settled.Blood transfusion = Trasfusione del sangueArticle
- Plasma pathways for Low and Middle Income Countries - needed more than ever.Blood transfusion = Trasfusione del sangueArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
objectivesPressures on the supply of plasma-derived medicinal products (PDMPs) have led to the efforts to increase the level of plasma collected by public health authorities. MATERIALS AND
methodsPublic blood collectors were assessed regarding their routes towards domestically sourced plasma and PDMPs.
resultsThe collectors' operations were specified and analysed. Models were classified according to the type of plasma collection system and contract fractionation arrangements.
conclusionCommitment and control to a public plasma collection system are the key features that need to underpin plasma collection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.